Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ivan D. Osipov"'
Autor:
Ivan D. Osipov, Valeriia A. Vasikhovskaia, Daria S. Zabelina, Sergei S. Kutseikin, Antonina A. Grazhdantseva, Galina V. Kochneva, Julia Davydova, Sergey V. Netesov, Margarita V. Romanenko
Publikováno v:
Viruses, Vol 15, Iss 1, p 182 (2023)
Human Adenovirus type 6 (HAdV-C6) is a promising candidate for the development of oncolytic vectors as it has low seroprevalence and the intrinsic ability to evade tissue macrophages. However, its further development as a therapeutic agent is hampere
Externí odkaz:
https://doaj.org/article/3de0d61be4f94d838bfe11f699d11d9b
Publikováno v:
Pharmaceutics, Vol 13, Iss 1641, p 1641 (2021)
Pharmaceutics
Pharmaceutics
Adenovirus vectors are the most frequently used agents for gene therapy, including oncolytic therapy and vaccine development. It’s hard to overestimate the value of adenoviruses during the COVID-19 pandemic as to date four out of four approved vira
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f06103c4c08fdfcd4e5c37e89d15530
https://www.mdpi.com/1999-4923/13/10/1641
https://www.mdpi.com/1999-4923/13/10/1641
Autor:
Ekaterina A. Potter, Sergey V. Netesov, Sergey S. Bogachev, Ivan A. Razumov, Galina V. Kochneva, Mariya S. Sizova, Anastasia S. Proskurina, A. A. Grazhdantseva, O. S. Taranov, Margarita V. Romanenko, Genrikh S. Ritter, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Ivan D. Osipov, Omigov Vv, E. V. Dolgova, Sergey I. Bayborodin
Publikováno v:
Anticancer Research. 39:6073-6086
BACKGROUND/AIM Oncolytic adenoviruses are promising therapeutic agents against both the bulk of tumor cells and cancer stem cells. The present study intended to test the oncolytic capability of adenovirus serotype 6 (Ad6), which has a lower seropreva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f25a650d15eaaf25159ae94de04ab438
https://doi.org/10.21873/anticanres.13815
https://doi.org/10.21873/anticanres.13815
Autor:
E. Yu. Rykova, Yu. B. Yurchenko, Ivan D. Osipov, Olga E. Bryzgunova, O. A. Pashkovskaya, Pavel P. Laktionov, M. M. Zaripov, Ivan A. Zaporozhchenko, S. V. Yarmoschuk, A. A. Zheravin, E. A. Lekchnov
Publikováno v:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 12:156-163
Urine of prostate cancer patients contains tumor-specific biopolymers, including protein- and microvesicles-associated miRNAs that can potentially be used as oncomarkers. Previously we have characterized urinary extracellular vesicles and demonstrate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c85e8d6519cb10a0cddf1ec08b8fa0ed
https://doi.org/10.1134/s1990750818020142
https://doi.org/10.1134/s1990750818020142
Autor:
Ivan D, Osipov, Ivan A, Zaporozhchenko, Anna A, Bondar, Marat M, Zaripov, Vladimir E, Voytsitskiy, Valentin V, Vlassov, Pavel P, Laktionov, Evgeny S, Morozkin
Publikováno v:
Advances in experimental medicine and biology. 924
Expression levels of five miRNAs (miR-19b, miR-21, miR-126, miR-141, miR-205) were measured in the plasma of healthy donors and prostate cancer patients. It was shown that miR-141 expression level efficiently discriminates early stage prostate cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bcad07d763a38de61de93e4308847124
https://pubmed.ncbi.nlm.nih.gov/27753010
https://pubmed.ncbi.nlm.nih.gov/27753010
Autor:
Valentin V. Vlassov, Anna A Bondar, E. Morozkin, M. M. Zaripov, Ivan A. Zaporozhchenko, Ivan D. Osipov, Vladimir E. Voytsitskiy, Pavel P. Laktionov
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783319420424
Expression levels of five miRNAs (miR-19b, miR-21, miR-126, miR-141, miR-205) were measured in the plasma of healthy donors and prostate cancer patients. It was shown that miR-141 expression level efficiently discriminates early stage prostate cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00b5d25093f377e69ab50542a4bf1981
https://doi.org/10.1007/978-3-319-42044-8_2
https://doi.org/10.1007/978-3-319-42044-8_2
